Arcadia Biosciences (RKDA) Non-Current Assets (2014 - 2025)

Arcadia Biosciences has reported Non-Current Assets for 12 years, with the latest figure at $190000.0 in Q4 2025.

• For the quarter ending Q4 2025, Non-Current Assets fell 95.56% year-over-year to $190000.0; the trailing twelve-month figure through Dec 2025 stood at $4.7 million (down 73.88% YoY), and the FY2025 full-year result was $190000.0, down 95.56% from the prior year.
• Non-Current Assets for Q4 2025 stood at $190000.0, down from $197000.0 in the prior quarter.
• The five-year high for Non-Current Assets was $19.9 million in Q2 2021, with the low at $190000.0 in Q4 2025.
• Historically, Non-Current Assets has averaged $5.8 million across 5 years, with a median of $4.4 million in 2022.
• Annual changes were most pronounced in 2021 — Non-Current Assets jumped 70.19% — and 2025, when it plunged 95.76%.
• Arcadia Biosciences' Non-Current Assets stood at $8.5 million in 2021, then plunged by 58.69% to $3.5 million in 2022, then jumped by 34.31% to $4.7 million in 2023, then declined by 9.68% to $4.3 million in 2024, then sank by 95.56% to $190000.0 in 2025.
• The last three Non-Current Assets figures came in at $190000.0 (Q4 2025), $197000.0 (Q3 2025), and $209000.0 (Q2 2025), per Business Quant data.